TIS tissue therapies limited

a proper update , page-14

  1. 9,445 Posts.
    Fair enough BUT what about my main point,Think like a prospective commercial partner. Take your shareholder glasses off!

    the players can already satisfy and profit from 50% of the market with their existing product. Anything they pay for new product will only benefit them some portion beyond the first 50%.

    So how good is this product at getting 100% heal results beyond 50%?


    COMMERCIALLY SPEAKING, why is this of value to the "partners"? Why would they wish to pay $millions and millions for a small percentage increase?

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.